Search results
Seattle Genetics (SGEN) Reports Q2 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 9 months agoSeattle Genetics (SGEN) delivered earnings and revenue surprises of -44.87% and 8.67%, respectively,...
Strength Seen in Seattle Genetics (SGEN): Can Its 14.5% Jump Turn into More Strength?
Zacks via Yahoo Finance· 1 year agoSeattle Genetics (SGEN) saw its shares surge in the last session with trading volume being higher...
Seattle Genetics (SGEN) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Zacks via Yahoo Finance· 6 months agoSeattle Genetics (SGEN) possesses the right combination of the two key ingredients for a likely...
Seattle Genetics (SGEN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Zacks via Yahoo Finance· 9 months agoWhile the top- and bottom-line numbers for Seattle Genetics (SGEN) give a sense of how the business...
Why Seattle Genetics, Alkermes Are Currently Outperforming Their Peers
Investor's Business Daily· 1 year agoBiotechs Seattle Genetics and Alkermes handily beat Wall Street's fourth-quarter estimates Thursday,...
Why Is Seattle Genetics (SGEN) Down 0.7% Since Last Earnings Report?
Zacks via Yahoo Finance· 5 months agoIt has been about a month since the last earnings report for Seattle Genetics (SGEN). Shares have...
Here's Why Seattle Genetics (SGEN) is a Great Momentum Stock to Buy
Zacks via Yahoo Finance· 2 years agoMomentum investing is all about the idea of following a stock's recent trend, which can be in either...
Seattle Genetics (SGEN) Now Trades Above Golden Cross: Time to Buy?
Zacks via Yahoo Finance· 2 years agoAfter reaching an important support level, Seagen Inc. (SGEN) could be a good stock pick from a...
Analyst Report: Seagen Inc.
Morningstar Research via Yahoo Finance· 2 years agoSeagen Inc. (formerly known as Seattle Genetics) is a biotech firm that develops and commercializes therapies to treat cancers. Seagen’s therapies are...
Why Is Iovance Biotherapeutics (IOVA) Down 9.2% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 year agoA month has gone by since the last earnings report for Iovance Biotherapeutics (IOVA). Shares have...
